Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Separation or purification
Reexamination Certificate
2011-01-18
2011-01-18
Robinson, Hope A (Department: 1652)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Separation or purification
C530S350000, C435S007100, C435S091200
Reexamination Certificate
active
07872108
ABSTRACT:
Compositions and methods for the isolation and manipulation of misfolded, or partially misfolded, proteins present in blood and other biological materials are provided. In one aspect of the invention, the compositions, hereinafter termed “proteons” are comprised of misfolded proteins. Also provided are compositions and methods for the isolation and manipulation of proteon nucleation centers (PNCs) upon which the proteons of the present in blood and other biological materials form. In another aspect of the invention, the PNCs are comprised of metallic nanoclusters.
REFERENCES:
patent: 5143837 (1992-09-01), Sova et al.
patent: 5874238 (1999-02-01), Potempa et al.
patent: 6036774 (2000-03-01), Lieber et al.
patent: 7138255 (2006-11-01), Vodyanoy
patent: 2007/0122799 (2007-05-01), Vodyanoy et al.
patent: 2007/0128642 (2007-06-01), Vodyanoy et al.
patent: 96/37282 (1996-11-01), None
patent: WO 98/53849 (1998-12-01), None
patent: WO 02/073210 (2002-09-01), None
Houston et al., “Tramsmission of BSE by blood transfusion in sheep”, The Lancet, Sep. 16, 2000, pp. 999-1000, vol. 356.
Lisiecki et al., “Syntheses of Copper nanoparticles in gelified microemulsion and in reverse micelles”, Journal of Molecular Liquids, 1997, pp. 251-261, vol. 72.
Shaked et al., “Copper Binding to the PrP Isoforms: a Putative Marker of Their Conformation and Function”, Journal of Virology, Sep. 2001, pp. 7872-7874, vol. 75, No. 17.
Geschwind, Michael D. (M.D., Ph.D.), et al, “Challenging the Clinical Utility of the 14-3-3 Protein for the Diagnosis of Sporadic Creutzfeldt-Jakob Disease”, Arch Neurol, vol. 60, Jun. 2003, pp. 813-816.
Rahman, Qamar, et al, “Evidence That Ultrafine Titanium Dioxide Induces Micronuclei and Apoptosis in Syrian Hamster Embryo Fibroblasts”, Environmental Health Perspectives, vol. 110, No. 8, Aug. 2002, pp. 797-800.
Aguzzi, A., “Prion Diseases, Blood and the Immune System: Concerns and Reality,”Haematologica, 2000, pp. 3-10, vol. 85, No. 1.
Aguzzi, A., “Blood Simple Prion Diagnostics,”Nature Medicine, 2001, pp. 289-290, vol. 7, No. 3, Nature Publishing Group.
Aiken III, J.D., & R.G. Finke, “A Review of Modern Transition-Metal Nanoclusters: Their Synthesis, Characterization, and Applications in Catalysis,”Journal of Molecular Catalysis A: Chemical, 1999, pp. 1-44, vol. 145, Elsevier Science B.V.
Attwood, T.K., “Metals in Prion Disease,”Trends in Biotechnology, 2002, p. 235, vol. 20, No. 6.
Binns et al., “Synchrotron Radiation Studies of Mass-Selected Fe Nanoclusters Deposited in Situ,”Eur. Phys. J.D., 2001, pp. 189-192, vol. 16.
Brown, P., et al., “Blood Infectivity and the Prospects for a Diagnostic Screening Test in Creutzfeldt-Jakob Disease,”J. Lab. Clin. Med., 2001, pp. 5-13, vol. 137, Mosby Inc.
Bush, A.I., “Metals and Neuroscience,”Current Opinions in Chemical Biology, 2000, pp. 184-191, vol. 4, Elsevier Science Ltd.
Bush, A., et al., “Rapid Induction of Alzheimer A Beta Amyloid Formation by Zinc,”Science, 1994, pp. 1464-1467, vol. 265, No. 5177.
Bush, A.I., “Metal Complexing Agents as Therapies for Alzheimer's Disease,”Neurobiology of Aging, 2002, pp. 1031-1038, vol. 23, Elsevier Science Inc.
Campbell, A., et al., “Mechanisms by which Metals Promote Events Connected to Neurodegenerative Diseases,”Brain Research Bulletin, 2001, pp. 125-132, vol. 55, No. 2, Elsevier Science Inc.
Carrel, R.W., & D.A. Lomas, “Conformational Disease,”Lancet, 1997, pp. 134-138, vol. 350.
Dyson et al,Biophysical J., 2002, vol. 82, p. 824.
Gerner, C., “Biochemische Analyse Endobiontischer Strukturen aus dem Menshlichen Blut,” [“Biochemical Analysis of Endobiontic Structures from Human Blood”]Curriculum Oncologicum01, Jan. 7, 1997.
Greschwind et al,Neurology, 2002, vol. 58, p. A135.
Haritani et al., “Hydrated autoclave pretreatment enhancement of prion protein immunoreactivity in formalin-fixed bovine spongiform encephalopathy-affected brain,”Acta Neuropathologica, Jan. 1994, vol. 87, No. 1, pp. 86-90.
Harper, J.D. & P.T. Lansbury, Jr., “Models of Amyloid Seeding in Alzheimer's Disease and Scrapie: Mechanistic Truths and Physiological Consequences of the Time-Dependent Solubility of Amyloid Proteins,”Ann. Rev. Biochem.,1997, vol. 66, pp. 385-407, Annual Reviews Inc.
Jaikaran and Clark,Biochimica et Biophysica Acta, 2001, vol. 1537, pp. 179-203.
Kannan et al., J. Biol. Chem., 1988, vol. 263, pp. 13766-13773.
Krasemann et al., “Induction of antibodies against human prion proteins (PrP) by DNA-mediated immunization of PrP0/0 mice.”J Immunol Methods., Dec. 15, 1996, vol. 199, No. 2, p. 109-118.
Lehmann, S., “Metal Ions and Prion Diseases,”Current Opinion in Chemical Biology, 2002, vol. 6, pp. 187-192, Elsevier Science Ltd.
Liu, C., & H. Xu, “The Metal Site as a Template for the Metalloprotein Structure Formation,”Journal of Inorganic Biochemistry, 2002, vol. 88, pp. 77-86, Elsevier Science B.V.
Otvos, J.D., & I.M. Armitage, “Structure of the Metal Clusters in Rabbit Liver Metallothionen,”Proc. Natl. Acad. Sci. USA., Dec. 1980, vol. 77, No. 12, pp. 7094-7098.
Prusiner,Science, 1992, vol. 252, pp. 1515-1522.
Rhodes, E., et al., “Aggregation of an Amyloidogenic Fragment of Human Islet Emyloid Polypeptide,”Biochemica et Biophysica Acta, 2000, pp. 230-238, vol. 1476, Elsevier Science B.V.
Saborio, G., et al, “Sensitive Detection of Pathological Prion Protein by Cyclic Amplification of Protein Misfolding,”Nature, 2001, pp. 810-813, vol. 411, Macmillan Magazines Ltd.
Schluter et al.,PNAS, 1986, vol. 83, pp. 6137-6141.
Soto, C., et al., “Cyclic Amplification of Protein Misfolding: Application to Prion-Related Disorders and Beyond,”Trends in Neurosciences, 2002, pp. 390-394, vol. 25, No. 8, Elsevier Science Ltd.
Soto,FEBS Letters, 2001, vol. 498, pp. 204-207.
Thackray, A., et al, “Metal Imbalance and Compromised Antioxidant Function are Early Changes in Prion Disease,”Biochem. J., 2002, pp. 253-258, vol. 362.
Ursini et al,Trends Mol. Med., 2001, vol. 8, pp. 370-374.
Watanabe et al., “Inhibition against heat coagulation of Ovotransferrin by Ovalbumin Dry-Heated at 120 Degrees,”C.J. Agric. Food Chem., Sep. 2000, vol. 48, No. 9, pp. 3965-3972.
Wetterberg et al,Neurosci Lett., 2001, vol. 329, pp. 91-95.
Wille et al.,Biophysical J., 2002, vol. 82, p. 825.
Wille et al.,PNAS, 2002, vol. 99, pp. 3563-3568.
Kapoor et al., “Laser-induced fragmentation and melting of cadmium and copper nanoparticles”, Materials Research Bulletin, 2000, 35(13).
Makeig et al., “Response: Event-related brain dynamics-unifying brain electrophysiology”, Trends in Neurosciences, Aug. 2002, 25(8):390.
Rataboul et al., “Synthesis and Characterization of Monodisperse Zinc and Zinc Oxide Nanoparticles from the Organometallic Precursor [Zn(C6H11)2]”, Journal of Organometallic Chemistry, 2002, 643-644.
Rivas et al., “First Steps Towards Tailoring Fine and Ultrafine Iron Particles Using Microemulsions”, IEEE Transactions on Magnetics, 1993, 29(6).
Samoylov et al., “Novel Metal Clusters Isolated from Blood are Lethal to Cancer Cells”, Cells Tissues Organs, 2005, 179:115-124.
Yeadon et al., “In-situ Observations of Classical Grain Growth Mechanisms During Sintering of Copper nanoparticles on (001) Copper”, Applied Physics Letters, 1997, 71(12).
Pustovyy Oleg M.
Samoylov Alexandre M.
Vodyanoy Vitaly J.
Andrus Sceales Starke & Sawall LLP
Auburn University
Robinson Hope A
LandOfFree
Processes for isolating proteon nucleation centers (PNCs)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Processes for isolating proteon nucleation centers (PNCs)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Processes for isolating proteon nucleation centers (PNCs)... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2726380